UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer

Clinical cancer research, 2013-07, Vol.19 (13), p.3693-3702

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR + , HER2 - breast cancer that had progressed during or after prior endocrine therapy

Breast cancer research : BCR, 2017-02, Vol.19 (1), p.18-18, Article 18

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT214: CANOPY-1: Safety run-in results from phase (ph) 3 study of canakinumab (CAN) or placebo (PBO) in combination (comb) with pembrolizumab (PEM) plus platinum-based doublet chemotherapy (Ctx) as 1st line therapy in patients (pts) with advanced or metastatic NSCLC

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.CT214-CT214

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract C100: Safety run-in results from phase 3 study of canakinumab (CAN) or placebo in combination with pembrolizumab (PEM) plus platinum-based doublet chemotherapy (Ctx) as 1st line therapy in patients (pts) with advanced or metastatic NSCLC (CANOPY-1)

Molecular cancer therapeutics, 2019-12, Vol.18 (12_Supplement), p.C100-C100

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT037: Canakinumab in combination with first-line (1L) pembrolizumab plus chemotherapy for advanced non-small cell lung cancer (aNSCLC): Results from the CANOPY-1 phase 3 trial

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.CT037-CT037

2022

Link zum Volltext

Verfügbarkeit prüfen

Dovitinib plus fulvestrant in postmenopausal endocrine resistant HER2-/ HR+ breast cancer: A phase II, randomized, placebo-controlled study

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.TPS651-TPS651

2013

Link zum Volltext

Verfügbarkeit prüfen

Velocity Dealiased Spectral Estimators of Range Migrating Targets using a Single Low-PRF Wideband Waveform

IEEE transactions on aerospace and electronic systems, 2013-01, Vol.49 (1), p.244-265

2013

Link zum Volltext
IEEE_Xplore

A new high pressure form of Ba3NiSb2O9

Journal of solid state chemistry, 2016-05, Vol.237, p.166-173

2016

Link zum Volltext

Verfügbarkeit prüfen

"Rehab for all!" Is it too early in pulmonary arterial hypertension?

The European respiratory journal, 2019-11, Vol.54 (5), p.1901558

2019

Link zum Volltext

Verfügbarkeit prüfen

Fast coherent integration for migrating targets with velocity ambiguity

2011 IEEE RadarCon (RADAR), 2011, p.027-032

2011

Link zum Volltext
IEEE_Xplore

APG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesis

Oncotarget, 2016-03, Vol.7 (12), p.14898-14911

2016

Link zum Volltext

Verfügbarkeit prüfen

A new high pressure form of Ba{sub 3}NiSb{sub 2}O{sub 9}

Journal of solid state chemistry, 2016-05, Vol.237

2016

Link zum Volltext

Verfügbarkeit prüfen

APG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesis , on behalf of the Groupe Francophone des Myélodysplasies

Oncotarget, 2016

2016

Link zum Volltext

Verfügbarkeit prüfen

Écrire l’histoire environnementale au xxie siècle: Sources, méthodes, pratiques

2022

Link zum Volltext

Verfügbarkeit prüfen

Identifying almost identical phases by 3D electron diffraction

Acta crystallographica. Section A, Foundations and advances, 2014-08, Vol.70 (a1), p.C373-C373

2014

Link zum Volltext

Verfügbarkeit prüfen

A Migrating Target Indicator for wideband radar

2010 IEEE Sensor Array and Multichannel Signal Processing Workshop, 2010, p.249-252

2010

Link zum Volltext
IEEE_Xplore

Modified Capon and APES for spectral estimation of range migrating targets in wideband radar

2010 IEEE Radar Conference, 2010, p.1280-1285

2010

Link zum Volltext
IEEE_Xplore

ChemInform Abstract: A New High Pressure Form of Ba 3 NiSb 2 O 9

ChemInform, 2016-05, Vol.47 (24)

2016

Link zum Volltext

Verfügbarkeit prüfen

Clutter suppression for moving targets detection with wideband radar

2011 19th European Signal Processing Conference, 2011, p.427-430

2011

Link zum Volltext

Verfügbarkeit prüfen

ChemInform Abstract: A New High Pressure Form of Ba3NiSb2O9

ChemInform, 2016-05, Vol.47 (24), p.no-no

2016

Link zum Volltext

Verfügbarkeit prüfen

Coherent integration for wideband LFMCW applied to PARSAX experimental data

2011 8th European Radar Conference, 2011, p.257-260

2011

Link zum Volltext
IEEE_Xplore

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(22)

Publikationsform

Sprache

Englisch
(22)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(11)
Life Sciences & Biomedicine
(6)
Wideband
(6)
Humans
(5)
Oncology
(5)
Engineering
(4)
Engineering, Electrical & Electronic
(4)
Female
(4)
Technology
(4)
Adult
(3)
Aged
(3)
Clutter
(3)
Doppler Effect
(3)
Middle Aged
(3)
Neoplasm Staging
(3)
Telecommunications
(3)
Aged, 80 And Over
(2)
Antineoplastic Agents - Therapeutic Use
(2)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(2)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ceritinib versus chemotherapy in patients with ALK -rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial

Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer

Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR + , HER2 - breast cancer that had progressed during or after prior endocrine therapy

Abstract CT214: CANOPY-1: Safety run-in results from phase (ph) 3 study of canakinumab (CAN) or placebo (PBO) in combination (comb) with pembrolizumab (PEM) plus platinum-based doublet chemotherapy (Ctx) as 1st line therapy in patients (pts) with advanced or metastatic NSCLC

Abstract C100: Safety run-in results from phase 3 study of canakinumab (CAN) or placebo in combination with pembrolizumab (PEM) plus platinum-based doublet chemotherapy (Ctx) as 1st line therapy in patients (pts) with advanced or metastatic NSCLC (CANOPY-1)

Abstract CT037: Canakinumab in combination with first-line (1L) pembrolizumab plus chemotherapy for advanced non-small cell lung cancer (aNSCLC): Results from the CANOPY-1 phase 3 trial

Dovitinib plus fulvestrant in postmenopausal endocrine resistant HER2-/ HR+ breast cancer: A phase II, randomized, placebo-controlled study

Velocity Dealiased Spectral Estimators of Range Migrating Targets using a Single Low-PRF Wideband Waveform

A new high pressure form of Ba3NiSb2O9

"Rehab for all!" Is it too early in pulmonary arterial hypertension?

Fast coherent integration for migrating targets with velocity ambiguity

APG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesis

A new high pressure form of Ba{sub 3}NiSb{sub 2}O{sub 9}

APG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesis , on behalf of the Groupe Francophone des Myélodysplasies

Écrire l’histoire environnementale au xxie siècle

Écrire l’histoire environnementale au xxie siècle: Sources, méthodes, pratiques

Identifying almost identical phases by 3D electron diffraction

A Migrating Target Indicator for wideband radar

Modified Capon and APES for spectral estimation of range migrating targets in wideband radar

ChemInform Abstract: A New High Pressure Form of Ba 3 NiSb 2 O 9

Clutter suppression for moving targets detection with wideband radar

ChemInform Abstract: A New High Pressure Form of Ba3NiSb2O9

Coherent integration for wideband LFMCW applied to PARSAX experimental data

Suchergebnisse filtern